Tessa De Vrieze

Dr. Tessa De Vrieze


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2015 in Archives of Physical Medicine and Rehabilitation
Verified
Journal Article
Closed access
NGNick Gebruers
Nick Gebruers
HVHanne Verbelen
Hanne Verbelen
TVTessa De Vrieze
Tessa De Vrieze
DCDorith Coeck
Dorith Coeck
WTWiebren Tjalma
Wiebren Tjalma

28 October 2019 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
TVTessa De Vrieze
Tessa De Vrieze
INInes Nevelsteen
Ines Nevelsteen
Sarah ThomisSarah Thomis
Sarah Thomis
AGAn De Groef
An De Groef
WTWiebren Tjalma
Wiebren Tjalma
Nele DevoogdtNele Devoogdt
Nele Devoogdt

1 September 2017 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Closed access
NGNick Gebruers
Nick Gebruers
HVHanne Verbelen
Hanne Verbelen
TVTessa De Vrieze
Tessa De Vrieze
LVLore Vos
Lore Vos
Nele DevoogdtNele Devoogdt
Nele Devoogdt
WTWiebren Tjalma
Wiebren Tjalma

1 June 2017 in Musculoskeletal Science and Practice
Verified
Journal Article
Closed access
AGAn De Groef
An De Groef
MMMira Meeus
Mira Meeus
TVTessa De Vrieze
Tessa De Vrieze
LVLore Vos
Lore Vos
MKMarijke Van Kampen
Marijke Van Kampen
Nele DevoogdtNele Devoogdt
Nele Devoogdt

1 June 2019 in Lymphatic Research and Biology
Verified
Journal Article
Closed access
TVTessa De Vrieze
Tessa De Vrieze
LVLore Vos
Lore Vos
NGNick Gebruers
Nick Gebruers
AGAn De Groef
An De Groef
LDLore Dams
Lore Dams
Nele DevoogdtNele Devoogdt
Nele Devoogdt
Background: Lymphedema is associated with significant physical and psychosocial problems. The Lymphedema Functioning, Disability and Health questionnaire for upper limb lymphedema is a valid and reliable tool quantifying the amount of problems in functioning in patients with breast cancer-related lymphedema. Patients suggested a revision of the scoring system to facilitate completion of the questionnaire. Therefore, adjustment of the questionnaire was carried out by implementing a numeric rating scale instead of the existing visual analog scale. Purpose of this study was to investigate reliability and validity of the revised Lymph-ICF, called the Lymph-ICF-UL. Methods and Results: Reliability and validity of the Lymph-ICF-UL were examined in 56 participants with upper limb lymphedema. Intraclass correlation coefficients for test-retest reliability ranged from 0.79 to 0.95. Cronbach's alpha coefficients for internal consistency were higher than 0.80. Face and content validity were very good because the scoring system was clear for all participants (100%), questions were understandable for all participants (100%), and all complaints due to arm lymphedema were mentioned by 98% of the participants. Construct validity was good. Convergent validity was established since four out of five expected domains of the Lymph-ICF-UL showed a moderate correlation with expected domains of the 36-Item Short-Form Health Survey questionnaire. There was good divergent validity because seven out of nine hypotheses assessing divergent validity were accepted. Conclusion: The Lymph-ICF-UL is a reliable and valid questionnaire using a simplified and clearer scoring procedure to assess impairments in function, activity limitations, and participation restrictions of patients with breast cancer-related arm lymphedema.

12 April 2022 in Journal of Physiotherapy
Verified
Journal Article
Open access
TVTessa De Vrieze
Tessa De Vrieze
NGNick Gebruers
Nick Gebruers
INInes Nevelsteen
Ines Nevelsteen
SFSteffen Fieuws
Steffen Fieuws
STSarah Thomis
Sarah Thomis
NDNele Devoogdt
Nele Devoogdt
When added to decongestive lymphatic therapy (DLT), what is the effect of fluoroscopy-guided manual lymphatic drainage (MLD) versus traditional MLD or placebo MLD for the treatment of breast cancer-related lymphoedema (BCRL)? Multicentre, three-arm, randomised controlled trial with concealed allocation, intention-to-treat analysis and blinding of assessors and participants. At five hospitals in Belgium, 194 participants with unilateral chronic BCRL were recruited. All participants received standard DLT (education, skin care, compression therapy and exercises). Participants were randomised to also receive fluoroscopy-guided MLD (n = 65), traditional MLD (n = 64) or placebo MLD (n = 65). Participants received 14 sessions of physiotherapy during the 3-week intensive phase and 17 sessions during the 6-month maintenance phase. Participants performed self-management on the other days. All outcomes were measured: at baseline; after the intensive phase; after 1, 3 and 6 months of maintenance phase; and after 6 months of follow-up. The primary outcomes were reduction in excess volume of the arm/hand and accumulation of excess volume at the shoulder/trunk, with the end of the intensive phase as the primary endpoint. Secondary outcomes included daily functioning, quality of life, erysipelas and satisfaction. Excess lymphoedema volume decreased after 3 weeks of intensive treatment in each group: 5.3 percentage points of percent excessive volume (representing a relative reduction of 23.3%) in the fluoroscopy-guided MLD group, 5.2% (relative reduction 20.9%) in the traditional MLD group and 5.4% (relative reduction 24.8%) in the placebo MLD group. The effect of fluoroscopy-guided MLD was very similar to traditional MLD (between-group difference 0.0 percentage points, 95% CI -2.0 to 2.1) and placebo MLD (-0.2 percentage points, 95% CI -2.1 to 1.8). Fluid accumulated at the shoulder/trunk in all groups. The average accumulation with fluoroscopy-guided MLD was negligibly less than with traditional MLD (-3.6 percentage points, 95% CI -6.4 to -0.8) and placebo MLD (-2.4 percentage points, 95% CI -5.2 to 0.4). The secondary outcomes also showed no clinically important between-group differences. In patients with chronic BCRL, MLD did not provide clinically important additional benefit when added to other components of DLT. NCT02609724.